Clinical Immunology Gastric Cancer Increase the Percentage of Intermediate (CD14++CD16+) and Nonclassical (CD14+CD16+) Monocytes
Central-European Journal of Immunology - Poland
doi 10.5114/ceji.2012.32725
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2012
Authors
Publisher
Termedia Sp. z.o.o.